To assess the clinical significance of CKS1B expression in PDAC, we analyzed data from the TCGA PDAC cohort and found statistically significant associations between CKS1B expression and several patient characteristics, including history of radiotherapy, chronic pancreatitis history, age (<60 years), early-stage PDAC classification (Grade I), and T2 stage (Supplementary Fig. 1). The gene discussed is CKS1B; the disease is chronic pancreatitis.